NZ598831A - Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same - Google Patents

Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same

Info

Publication number
NZ598831A
NZ598831A NZ598831A NZ59883111A NZ598831A NZ 598831 A NZ598831 A NZ 598831A NZ 598831 A NZ598831 A NZ 598831A NZ 59883111 A NZ59883111 A NZ 59883111A NZ 598831 A NZ598831 A NZ 598831A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical composition
parenteral administration
antimicrobial activity
preparing same
composition
Prior art date
Application number
NZ598831A
Inventor
Konstantin Valentinovich Gaidul
Viktor Lvovich Limonov
Aleksandr Valerevich Dushkin
Original Assignee
Viktor Lvovich Limonov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viktor Lvovich Limonov filed Critical Viktor Lvovich Limonov
Publication of NZ598831A publication Critical patent/NZ598831A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

598831 Disclosed herein is an antimicrobial pharmaceutical composition comprising a betalactam antibiotic and a finely dispersed nanostructured silica dioxide, wherein the composition is formulated for parenteral administration, and wherein the betalactam antibiotic and the finely dispersed nanostructured silica dioxide are present in the composition in a weight ratio of 10:1 to 75:1.
NZ598831A 2010-09-13 2011-05-11 Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same NZ598831A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EA201001449A EA021874B1 (en) 2010-09-13 2010-09-13 Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same
PCT/RU2011/000320 WO2012036585A1 (en) 2010-09-13 2011-05-11 Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same

Publications (1)

Publication Number Publication Date
NZ598831A true NZ598831A (en) 2013-11-29

Family

ID=45908207

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ598831A NZ598831A (en) 2010-09-13 2011-05-11 Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same

Country Status (9)

Country Link
JP (1) JP2013537190A (en)
CN (1) CN103096896A (en)
AU (1) AU2011302724C1 (en)
BR (1) BR112012023964A2 (en)
CA (1) CA2785228A1 (en)
EA (1) EA021874B1 (en)
MX (1) MX2012010535A (en)
NZ (1) NZ598831A (en)
WO (1) WO2012036585A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040058360A (en) * 1996-02-29 2004-07-03 후지사와 야꾸힝 고교 가부시키가이샤 A synthetic sweetener
JP2010500340A (en) * 2006-08-11 2010-01-07 パナセア バイオテック リミテッド Particles for delivering active ingredients, methods for their production and compositions
RU2377985C2 (en) 2006-12-25 2010-01-10 Сергей Михайлович Юдин Preparation for treating infectious diseases caused by multiresistant bacteria

Also Published As

Publication number Publication date
WO2012036585A1 (en) 2012-03-22
WO2012036585A8 (en) 2012-10-04
AU2011302724C1 (en) 2012-11-29
BR112012023964A2 (en) 2016-08-02
CA2785228A1 (en) 2012-03-22
CN103096896A (en) 2013-05-08
AU2011302724B2 (en) 2012-06-28
AU2011302724A1 (en) 2012-05-03
MX2012010535A (en) 2012-11-16
EA021874B1 (en) 2015-09-30
JP2013537190A (en) 2013-09-30
EA201001449A1 (en) 2012-02-28

Similar Documents

Publication Publication Date Title
IL232382A (en) Furo[3,2-d]pyrimidine derivatives, compositions comprising them and uses thereof in the manufacture of medicaments
WO2012047986A3 (en) Absorbent article with philic anhydrous lotion
AU2012327781B2 (en) Modified Y zeolite, method for preparing same, and use thereof
WO2011110930A3 (en) Rifaximin ready-to-use suspension
MY170878A (en) [1,2,3] triazolo [4,5-d] pyrimidine derivatives as agonists of the cannabinoid receptor 2
MX338707B (en) Ampk-activating heterocyclic compounds and methods for using the same.
MY156938A (en) Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
NZ616764A (en) Mannose derivatives as antagonists of bacterial adhesion
WO2012078902A3 (en) Proteostasis regulators
PH12015500746A1 (en) Benzamides
MX346248B (en) [1, 2, 3]triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 agonists.
MY172422A (en) Pyrazole compound and pharmaceutical use thereof
TN2014000001A1 (en) A new therapeutical composition containing apomorphine as active ingredient
WO2011061519A3 (en) Topical foam composition
MX2013006418A (en) Oxazolyl-methylether derivatives as alx receptor agonists.
PH12014502465A1 (en) Fluorinated bridged spiro[2.4]heptane derivatives as alx receptor agonists
MX340626B (en) Levoisovalerylspiramycin i, ii or iii, preparations, preparation methods and uses thereof.
MX356714B (en) Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction.
MX2012000955A (en) Pesticidal carboxamides.
WO2014062838A3 (en) Pkm2 modulators and methods for their use
MX2013013079A (en) Compositions comprising antibacterial agent and tazobactam.
AU2011298391A8 (en) Substituted N-phenethyltriazoloneacetamides and uses thereof
MY163185A (en) 2-methoxy-pyridin-4-yl derivatives
NZ598831A (en) Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same
MX2013002694A (en) Tetrahydroquinoline derivatives used as ampk activators.

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 MAY 2016 BY PIZZEYS PATENT AND TRADE MARK ATTORNEYS

Effective date: 20150416

LAPS Patent lapsed